Medicxi Ventures Management (Jersey) Ltd

Updated 3 days ago

Managed by Medicxi Ventures Management (Jersey) Ltd • Latest filing Q3 2026

Portfolio value

$126.7M

Q3 2026

Filings

Quarterly 13F history

Top-10 concentration

100.0%

Weight of largest holdings

Annualized return

—

Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table

3 positions as of Q3 2026

#	Stock	Value	Shares	% Portfolio	Change
1	P PHAT History → PHATHOM PHARMACEUTICALS INC	$54.5M	7.46M	43.02%	—
2	N NAMSW History → NEWAMSTERDAM PHARMA COMPANY	$53.1M	2.18M	41.90%	—
3	A AURA History → AURA BIOSCIENCES INC	$19.1M	3.04M	15.07%	—

PHATHOM PHARMACEUTICALS INC

Value

$54.5M

7.46M

% Port

43.02%

NEWAMSTERDAM PHARMA COMPANY

Value

$53.1M

2.18M

% Port

41.90%

AURA BIOSCIENCES INC

Value

$19.1M

3.04M

% Port

15.07%